Science and Research

A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

This is a first in human (FIH) clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8630 in healthy adults (Part A) and adult asthma patients on medium to high dose inhaled corticosteroids / Long-acting beta-agonists (Part B)

Study details
Study-ID: NCT05110976, 2021-004000-18
Study-ID: NCT05110976, 2021-004000-18
DZL Disease Area: AA
DZL Disease Area: AA
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center, DZL on steering board
DZL Role: DZL recruiting center, DZL on steering board
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: ARCN
DZL Participating Sites: ARCN
Start Date: 16.12.2021
Completion Date: 02.08.2023
Status: Closed
Status: Closed
DZL recruiting center, DZL on steering board
Link to Study


chevron-down